8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 Date of Report (Date of earliest event reported):  July 15, 2008

 Aceto Corporation

 (Exact name of registrant as specified in its charter)

 New York

 (State or Other Jurisdiction of Incorporation)

000-04217	11-1720520
(Commission File Number)	(IRS Employer Identification Number)

 One Hollow Lane, Suite 201, Lake Success, New York 11042

 (Address of Principal Executive Offices)

 (516) 627-6000

 (Registrant’s Telephone Number, Including Area Code)

 N/A

 (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

□  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14-12)

□  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))

□  Pre-commencement communications pursuant to Rule 13-e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition.

On July 15, 2008, Aceto Corporation, a New York corporation (the “Registrant”), issued

a press release to announce that the Company had exceeded $100 million in sales in the fiscal 2008 fourth quarter. A copy of the press release is attached as Exhibit 99.1 to this Report on Form 8-K.  The information in this Report shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 Item 9.01  Financial Statements and Exhibits.

(c) Exhibits

 Exhibit 99.1  Press Release issued by Aceto Corporation dated July15, 2008

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

	ACETO CORPORATION
	(Registrant)
Dated:  July 16, 2008	By:	/s/ Douglas Roth
		Douglas Roth
		Chief Financial Officer

EXHIBIT INDEX

 Exhibit No. Exhibits.

99.1 Press Release issued by Aceto Corporation dated July 15, 2008

EX-99.1

Exhibit 99.1

    Aceto Corporation One Hollow Lane Lake Success, New York 11042-1215

 NEWS RELEASE

FOR IMMEDIATE RELEASE

ACETO CORPORATION ANNOUNCES FOURTH QUARTER FISCAL 2008 SALES

EXCEED $100 MILLION

LAKE SUCCESS, NY – July 15, 2008 – Aceto Corporation (NASDAQ:ACET), a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals and crop protection products, today announced that the Company had exceeded $100 million in sales in the fiscal 2008 fourth quarter, the first time in the Company’s history that quarterly sales have reached this record level.

Leonard S. Schwartz, Chairman, CEO, and President of Aceto, stated, “We are very proud of exceeding $100 million in quarterly sales for the first time in the history of Aceto.  This marks an important milestone in the Company’s history and an especially gratifying one in that it comes in spite of the very difficult economic environment that we find ourselves operating in.”

As is our customary practice, the Company will announce the results of operations for its fiscal fourth quarter and year ended June 30, 2008 in early September.  A press release providing details of the earnings conference call and webcast will be distributed approximately two weeks prior to the earnings release.

ABOUT ACETO

Aceto Corporation, incorporated in 1947, is a global leader in the sourcing, regulatory support, marketing and distribution of chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals and crop protection products.  With a physical presence in ten countries, Aceto distributes over 1,000 chemicals and pharmaceuticals used principally as raw materials in the pharmaceutical, crop protection, surface coating/ink and general chemical consuming industries. Aceto’s global operations, including a staff of 26 in Shanghai and 14 in India are unique in the industry and enable its worldwide sourcing and regulatory capabilities. (ACET-F)

For information contact:

Theodore Ayvas

Director of Corporate Communications

& Investor Relations

Aceto Corporation

(516) 627-6000

www.aceto.com